April 02, 2025 16:30 ET | Source: Olema Oncology SAN FRANCISCO, April 02, 2025 (GLOBE NEWSWIRE) -- Olema Pharmaceuticals, Inc.…
CAMBRIDGE, Mass., March 21, 2025 (GLOBE NEWSWIRE) -- Immuneering Corporation (Nasdaq: IMRX), a clinical-stage oncology company seeking to develop and…
THE WOODLANDS, TX, March 21, 2025 (GLOBE NEWSWIRE) -- Autonomix Medical, Inc. (NASDAQ: AMIX) (“Autonomix” or the “Company”), a medical…
LEXINGTON, Mass., March 12, 2025 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences…
March 07, 2025 16:05 ET | Source: Ocular Therapeutix, Inc. BEDFORD, Mass., March 07, 2025 (GLOBE NEWSWIRE) -- Ocular Therapeutix,…
March 07, 2025 16:01 ET | Source: Replimune Group Inc WOBURN, Mass., March 07, 2025 (GLOBE NEWSWIRE) -- Replimune Group,…
March 05, 2025 17:52 ET | Source: Agios Pharmaceuticals, Inc. CAMBRIDGE, Mass., March 05, 2025 (GLOBE NEWSWIRE) -- Agios Pharmaceuticals,…
March 04, 2025 16:05 ET | Source: Definitive Healthcare Corp. FRAMINGHAM, Mass., March 04, 2025 (GLOBE NEWSWIRE) -- Definitive Healthcare…
February 28, 2025 16:00 ET | Source: Adverum Biotechnologies, Inc. REDWOOD CITY, Calif., Feb. 28, 2025 (GLOBE NEWSWIRE) -- Adverum…
February 27, 2025 18:00 ET | Source: Skye Bioscience, Inc. SAN DIEGO, Feb. 27, 2025 (GLOBE NEWSWIRE) -- Skye Bioscience,…
